PAR 1.69% 29.0¢ paradigm biopharmaceuticals limited..

Ann: PAR Successful Placement and Fully Underwritten ANREO, page-192

  1. 9,674 Posts.
    lightbulb Created with Sketch. 1232
    Thanks @Mangoman605.

    From my perspective the staged approach whilst protracted help mitigate the risk of missing primary end points and the end of 002-003. Stage 1 has now confirmed 2mg/kg x 1 and 1.5mg/kg x 2 is NOT the minimum effective dose. The known and preferred dose used in OA008, 2B and SAS of 2mg/kg x 2 is both effective and still SAFE. Interestingly also the combined n for these prior trials using 2mg/kg x 2 all showing statistical significance on primary end points being used on OA002-003 is greater than the proposed Stage 2 n.

    So we now wait for FDA to confirm we're good to move to preferred and known dosage of 2mg/kg x 2 for Stage 2.




 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
-0.005(1.69%)
Mkt cap ! $101.4M
Open High Low Value Volume
29.0¢ 29.3¢ 28.0¢ $57.32K 198.9K

Buyers (Bids)

No. Vol. Price($)
1 12454 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 4443 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.